Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Alcoholism, Clinical and Experimental Research|June 26, 2015
Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS AnalysesAmy B Hart, Henry R Kranzler
Current Topics in Behavioral Neurosciences|January 21, 2012
Genetic factors modulating the response to stimulant drugs in humansAmy B Hart, Harriet de Wit, Abraham A Palmer
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
Candidate gene studies of a promising intermediate phenotype: failure to replicateAmy B Hart, Harriet de Wit, Abraham A Palmer
Drug and Alcohol Dependence|June 7, 2015
Inter-observer reliability of DSM-5 substance use disordersCécile M Denis, Joel Gelernter, Amy B Hart, et al.
Addiction Biology|April 2, 2015
Which alcohol use disorder criteria contribute to the association of ADH1B with alcohol dependence?Amy B Hart, Kevin G Lynch, Lindsay Farrer, et al.
Psychopharmacology|April 7, 2015
Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associationsHaley L Yarosh, Shashwath A Meda, Harriet de Wit, et al.
Plos One|September 7, 2012
Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13)Amy B Hart, Barbara E Engelhardt, Margaret C Wardle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2016
Genome-Wide Association Study of Loneliness Demonstrates a Role for Common VariationJianjun Gao, Lea K Davis, Amy B Hart, et al.
Psychopharmacology|February 20, 2013
Psychopharmacology of theobromine in healthy volunteersMatthew J Baggott, Emma Childs, Amy B Hart, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2014
Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorderAmy B Hart, Eric R Gamazon, Barbara E Engelhardt, et al.
Pageof 2